Common use of Operating Policies and Procedures Clause in Contracts

Operating Policies and Procedures. You acknowledge that: (i) PHARMAC is required to pursue the objectives, carry out the functions, and otherwise comply with the statutory obligations, prescribed for PHARMAC in the New Zealand Public Health and Disability ▇▇▇ ▇▇▇▇; (ii) PHARMAC is subject to other statutory and public law obligations, which govern PHARMAC’s decision-making processes; (iii) PHARMAC has Operating Policies and Procedures (“OPPs”), which provide guidance on the way in which PHARMAC carries out its statutory responsibilities in relation to the management of the Pharmaceutical Schedule; (iv) PHARMAC’s OPPs may be amended or updated from time to time, following consultation with relevant groups; (v) the actions which PHARMAC may take under its OPPs include (without limitation): (A) listing new pharmaceuticals; (B) changing guidelines or restrictions on the prescribing and dispensing of listed pharmaceuticals; (C) changing the subsidy levels for pharmaceuticals as a result of PHARMAC adopting one of the strategies set out in the OPPs or by any other means; (D) amending the basis on which pharmaceuticals are classified into therapeutic groups and sub-groups; (E) delisting pharmaceuticals, or delisting all or part of a therapeutic group or sub-group; (F) changing the market dynamics for pharmaceuticals as a result of PHARMAC adopting one of the strategies set out in the OPPs; (G) any action taken by PHARMAC pursuant to its OPPs may impact on the listing of a pharmaceutical; (H) PHARMAC agrees not to apply, amend or update its OPPs in order to avoid any of PHARMAC’s obligations under this Agreement.

Operating Policies and Procedures. You acknowledge that: (i) PHARMAC Pharmac is required to pursue the objectives, carry out the functions, and otherwise comply with the statutory obligations, prescribed for PHARMAC Pharmac in the New Zealand Public Health and Disability ▇▇▇ ▇▇▇▇▇ Act; (ii) PHARMAC Pharmac is subject to other statutory and public law obligations, which govern PHARMACPharmac’s decision-making processes; (iii) PHARMAC Pharmac has Operating Policies and Procedures (“OPPs”), which provide guidance on the way in which PHARMAC Pharmac carries out its statutory responsibilities in relation to the management of the Pharmaceutical Schedule; (iv) PHARMACPharmac’s OPPs may be amended or updated from time to time, following consultation with relevant groups; (v) the actions which PHARMAC Pharmac may take under its OPPs include (without limitation): (A) listing new pharmaceuticals; (B) changing guidelines or restrictions on the prescribing and dispensing of listed pharmaceuticals; (C) changing the subsidy levels for pharmaceuticals as a result of PHARMAC Pharmac adopting one of the strategies set out in the OPPs or by any other means; (D) amending the basis on which pharmaceuticals are classified into therapeutic groups and sub-groups; (E) delisting pharmaceuticals, or delisting all or part of a therapeutic group or sub-group; (F) changing the market dynamics for pharmaceuticals as a result of PHARMAC Pharmac adopting one of the strategies set out in the OPPs; (G) any action taken by PHARMAC Pharmac pursuant to its OPPs may impact on the listing of a pharmaceutical; (H) PHARMAC Pharmac agrees not to apply, amend or update its OPPs in order to avoid any of PHARMACPharmac’s obligations under this Agreement.